Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210031574 210013939 1.71 97.7 Disease modification (D) 2016-10-23 2016-10-23 CYTARABINE 02 N 210035520 LENALIDOMIDE
210031575 210013940 1.75 70.4 Disease modification (D) 2016-07-26 2016-07-26 Hydroxycarbamide N N 210035533 RCEOP
210031576 210031598 null 90 null 2018-04-03 2018-08-10 CLL210 TRIAL N N 210035850 PMITCEBO-R
210031577 210013950 1.67 66 null 2014-02-15 2014-02-19 FLAG Y N 210036092 OFATUMUMAB
210031578 210013952 1.74 88.4 Adjuvant (A) 2017-10-25 2017-11-04 FCR IV - Cycle 2 onwards 02 N 210036454 TRASTUZUMAB
210031579 210013955 null 81 Curative (C) null 2014-10-20 RUXOLITINIB Y N 210036485 ABIRATERONE
210031580 210013959 null null Curative (C) 2019-10-03 2019-10-03 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE N N 210036496 CISPLATIN + GEMCITABINE + RITUXIMAB
210031581 210013961 null 52.3 Adjuvant (A) 2019-05-16 2019-05-19 CLARITY Trial 02 Y 210036578 CISPLATIN + GEMCITABINE + RITUXIMAB
210031582 210013963 null 61 Disease modification (D) 2015-07-25 2015-07-25 Sunitinib N null 210036643 ALL INDUCTION
210031583 210013968 1.65 61 Disease modification (D) 2016-03-22 2017-03-26 REGORAFENIB N N 210036881 UKALL 60+ TRIAL
210031584 210028242 1.72 29.2 Curative (C) 2019-07-23 2019-07-30 Cytarabine intrathecal null N 210036916 IRINOTECAN + MDG
210031585 210013970 1.85 75.6 Disease modification (D) 2014-04-02 2014-04-02 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE Y N 210036941 ALL
210031586 210013972 1.58 null Curative (C) 2017-07-31 2017-07-31 DOXORUBICIN 01 N 210037146 CYCLET
210031587 210013975 null 70.8 Curative (C) 2013-11-14 2013-11-14 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE null null 210037309 VAI
210031588 210013977 null null Palliative (P) 2016-08-21 2016-08-22 FCR IV - Cycle 2 onwards N N 210037404 CLARITY TRIAL
210031589 210022719 null 81.7 Curative (C) 2018-11-28 2018-11-29 Mitomycin Intravesical Y N 210037672 TRASTUZUMAB
210031590 210013980 1.79 50 Curative (C) 2019-10-12 2019-10-19 CODOX M N N 210037675 CLL210 TRIAL
210031591 210013987 1.73 66.599 Curative (C) 2018-02-20 2018-03-07 CYTARABINE 2 null 210038079 CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE
210031592 210013995 1.74 0 Palliative (P) 2018-08-31 2018-09-07 FCR IV - Cycle 2 onwards N N 210038641 CYCLO + FLUDARABINE + RITUXIMAB
210031593 210013996 null 105.9 Palliative (P) 2018-01-18 2018-02-09 ALL UKALL2003 C: Ph VII Maintenance null N 210038652 IMMUNOGLOBULIN
210031594 210022730 1.81 93 Adjuvant (A) 2015-11-23 2015-12-21 ALL UKALL2003 C: Ph VII Maintenance N N 210038996 ABIRATERONE
210031595 210014004 1.8 18.2 Disease modification (D) 2014-12-06 2014-12-06 LENALIDOMIDE + dexamethasone N N 210039065 CYTARABINE HD + METHOTREXATE HD
210031596 210014008 1.57 64.3 Curative (C) 2014-05-02 2014-05-22 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE 02 N 210039506 HYDROXYCARBAMIDE
210031597 210035180 1.83 78 Palliative (P) 2017-09-04 2017-09-12 Cyclophosphamide High Dose null N 210039555 DHAP
210031598 210014009 1.85 null Disease modification (D) 2016-10-01 2016-10-01 CYTARABINE + ETOPOSIDE 2 Y 210039663 FLUDARABINE + MELPHALAN
210031599 210014014 1.81 105.5 Disease modification (D) 2017-01-08 2017-10-25 CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE null N 210040040 ABVD
210031600 210014018 1.59 68.6 Palliative (P) 2018-08-18 2018-08-18 DAUNORUBICIN N N 210040051 DAUNORUBICIN + VNCRISTINE
210031601 210022736 1.56 90 Palliative (P) null 2017-02-18 DABRAFENIB + TRAMETINIB null Y 210040164 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
210031602 210014025 null 45.3 null 2017-09-11 2017-10-12 Trastuzumab Subcutaneous N N 210040409 HYDROXYCARBAMIDE
210031603 210014030 null 66.4 Disease modification (D) 2016-06-06 2016-06-26 FLUDARABINE N null 210040771 FLUDARABINE + MELPHALAN
210031604 210028260 1.69 72 null 2014-09-07 2014-10-22 Bevacizumab + Temozolomide Y N 210040788 DASATINIB + IDARUBICIN + VINCRISTINE
210031605 210014035 null 80.6 Disease modification (D) 2017-12-06 2017-12-06 Azacitidine N N 210041159 PACKER INDUCTION VINCRISTINE + RT
210031606 210022745 1.74 103.4 Curative (C) 2016-08-05 2017-04-01 CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE 2 N 210041453 LENALIDOMIDE
210031607 210014045 0 90 Palliative (P) 2013-05-31 2013-06-05 PACLITAXEL 2 N 210041720 DA
210031608 210022748 1.72 63.3 Curative (C) 2017-11-21 2019-08-12 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE N N 210041755 ABVD
210031609 210014050 1.81 10.7 Curative (C) 2018-06-01 2018-06-03 CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE N null 210041781 CARBOPLATIN + PACLITAXEL + RT
210031610 210028268 1.77 null Curative (C) 2015-12-24 2016-12-06 PACLITAXEL N Y 210042046 OBINUTUZUMAB
210031611 210022754 1.45 78.75 Palliative (P) 2015-08-12 2016-03-27 BR14 TRIAL N N 210042047 CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE
210031612 210028269 1.61 null Adjuvant (A) 2015-06-06 2015-06-06 PIXANTRONE 02 N 210012122 CYCLOPHOSPHAMIDE HIGH DOSE
210031613 210014065 1.63 55 Disease modification (D) null 2018-02-28 TRASTUZUMAB N N 210024514 RUXOLITINIB
210031614 210014068 0 64.4 Curative (C) 2018-12-11 2018-12-16 AML 18 TRIAL N null 210025987 BEAM
210031615 210033735 1.67 20.3 Palliative (P) 2016-03-20 2016-12-09 CYCLOPHOSPHAMIDE + CYTARABINE 02 N 210029013 ALEMTUZUMAB + ETOPOSIDE
210031616 210033735 1.88 117.5 Palliative (P) 2017-09-03 2017-09-08 CLARITY Trial 02 N 210029013 CYCLO + FLUDARABINE + RITUXIMAB
210031617 210014070 1.79 null Curative (C) 2019-07-11 2019-08-11 CNS Medbl Std Risk Maint Cisplatin N N 210030920 LENALIDOMIDE
210031618 210022767 0 60.8 Adjuvant (A) 2017-01-17 2017-01-17 CLL210 TRIAL N N 210032826 AML19 TRIAL
210031619 210014077 1.75 83.4 Disease modification (D) 2018-01-31 2018-01-31 Cytarabine HD + Methotrexate HD 2 N 210032863 CETUXIMAB + IRINOTECAN
210031620 210028274 null null Palliative (P) 2017-03-28 2017-10-06 Maintenance Therapy ALL N null 210034307 ICE
210031621 210033737 1.8 26.8 Palliative (P) 2017-07-07 2017-07-07 Capecitabine 2 null 210039936 DOXORUBICIN
210031622 210014089 1.56 98 Disease modification (D) null 2019-06-03 CISPLATIN + LOMUSTINE + VINCRISTINE null null 210041640 UKALL 60+ TRIAL
210031623 210014093 1.57 78.5 Palliative (P) 2019-12-24 2019-12-27 CNS Medbl Std Risk Maint Cisplatin N N 210013365 ALEMTUZUMAB + CYCLO + FLUDARABINE